Expression profiling of estrogen responsive genes using genomic and proteomic techniques for the evaluation of endocrine disruptors

Current Pharmacogenomics

Volumn 2, Issue 3, 2004, Pages 255-266

  Tanji, Masao ^a   Kiyama, Ryoiti ^a,b  

^a InfoGenes Co Ltd   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; DIETHYLSTILBESTROL; DIOXIN; ESTRADIOL; ESTRIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NONYLPHENOL; RAS PROTEIN; TRANSCRIPTION FACTOR AP 1;

BINDING ASSAY; CELL ASSAY; CELL GROWTH; CELL TYPE; CLUSTER ANALYSIS; DNA MICROARRAY; ENDOCRINE DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTROGEN ACTIVITY; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC ANALYSIS; GENETIC DATABASE; GENOMICS; HUMAN; HYPOTHESIS; LIGAND BINDING; MAMMAL CELL; NONHUMAN; PROTEIN FAMILY; PROTEOMICS; REPORTER GENE; REVIEW; SIGNAL TRANSDUCTION; YEAST CELL;

EID: 4444314777     PISSN: 15701603     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570160043377529     Document Type: Review

References (118)

1. Anderle, P.; Duval M.; Draghici, S.; Kuklin, A.; Littlejohn, T. G.; Medrano, J. F.; Vilanova. D.; Roberts, M. A. (2003) Gene expression databases and data mining. Biotechniques, Suppl., 36-44.
2. Arnold, S. F; Robinson, M. K.; Notides, A. C.; Guillette, L. J. Jr.; McLachlan J. A. (1996) A yeast estrogen screen for examining the relative exposure of cells to natural and xenoestrogens. Environ. Health Perspect, 104, 544-548.
3. Argyropoulos, C.; Nikiforidis, G. C.; Theodoropoulou, M.; Adamopoulos, P.; Boubali, S.; Georgakopoulos, T. N.; Paliogianni, F.; Papavassiliou, A. G.; Mouzaki, A.; (2004) Mining microarray data to identify transcription factors expressed in naive resting but not activated T lymphocytes. Genes Immun., 5, 16-25.
4. Babnigg, G.; Giometti, C. S.; (2003) ProteomeWeb: a web-based interface for the display and interrogation of proteomes. Proteomics, 3, 584-600.
5. Baker, V. A. (2001) Endocrine disrupters - testing strategies to assess human hazard. Toxicol. In Vitro, 15, 413-419.
6. Balaguer, P.; Joyeux, A.; Denison, M. S.; Vincent, R.; Gillesby, B. E.; Zacharewski, T. (1996) Assessing the estrogenic and dioxin-like activities of chemicals and complex mixtures using in vitro recombinant receptor-reporter gene assays. Can. J. Physiol. Pharmacol., 74, 216-222.
7. Becker, K. G.; White, S. L.; Muller, J.; Engel, J. (2000) BBID: the biological biochemical image database. Bioinformatics, 16, 745-746.
8. Becker, K.G.; Hosack, D. A.; Dennis, G. Jr.; Lempicki, R. A.; Bright, T. J.; Cheadle, C.; Engel, J. (2003) PubMatrix: a tool for multiplex literature mining. BMC Bioinformatics, 4, 61.
9. Bicciato, S.; Luchini, A.; Di Bello, C. (2004) Marker Identification and Classification of Cancer Types Using Gene Expression Data and SIMCA. Methods Inf. Med., 43, 4-8.
10. Blair, R. M.; Fang, H.; Branham, W. S.; Hass, B. S.; Dial, S. L.; Moland, C. L.; Tong, W.; Shi, L.; Perkins, R.; Sheehan, D. M. (2000) The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicol. Sci., 54, 138-153.
11. Bockaert, J.; Marin, P.; Dumuis, A.; Fagni, L. (2003) The 'magic tail' of G protein-coupled receptors: an anchorage for functional protein networks. FEBS Lett., 546, 65-72.
12. Boguski, M. S.; McIntosh, M. W. (2003) Biomedical informatics for proteomics. Nature, 422, 233-237.
13. Bradbury, A. R. M.; Velappan, N.; Verzillo, V.; Ovecka, M.; Marzari, R.; Sblattero, D.; Chasteen, L.; Siegel, R.; Pavlik, P. (2004) Antibodies in Proteomics. Antibody Engineering: Methods and Protocols, Ed. Lo BKC. Humana Press, New Jersey, pp. 519-546.
14. Branham, W. S.; Dial, S. L.; Moland, C. L.; Hass, B. S.; Blair, R. M.; Fang, H.; Shi, L.; Tong, W.; Perkins, R. G.; Sheehan, D. M. (2002) Phytoestrogens and mycoestrogens bind to the rat uterine estrogen receptor. J. Nutr., 132, 658-664.
15. Burch, J. B.; Evans, M. I.; Friedman, T. M.; O'Malley, P. J. (1988) Two functional estrogen response elements are located upstream of the major chicken vitellogenin gene. Mol. Cell. Biol., 8, 1123-1131.
16. Camby, I.; Kiss, R. (1993) In vitro estradiol-sensitivity characterization of the MCF-7, ZR-75, MDA-MB-231 and T47-D human breast neoplastic cell lines. Anticancer Res., 13, 2355-2360.
17. Castillo-Davis, C. I.; Hartl, D. L. (2003) GeneMerge - post-genomic analysis, data mining, and hypothesis testing. Bioinformatics, 19, 891-892.
18. Craigon, D. J.; James, N.; Okyere, J.; Higgins, J.; Jotham, J.; May, S. (2004) NASCArrays: a repository for microarray data generated by NASC's transcriptomics service. Nucleic Acids Res., 32, D575-D577.
19. Cullen, K. J.; Yee, D.; Bates, S. E.; Brunner, N.; Clarke, R.; Dickson, R. E.; Huff, K. K.; Paik, S.; Rosen, N.; Valverius, E.; et al. (1989) Regulation of human breast cancer by secreted growth factors. Acta Oncol., 28, 835-839.
20. Demirpence, E.; Duchesne, M. J.; Badia, E.; Gagne, D.; Pons, M. (1993) MVLN cells: a bioluminescent MCE-7-derived cell line to study the modulation of estrogenic activity. J. Steroid Biochem. Mol. Biol., 46, 355-364.
21. Deng, C. X.; Wang, R. H. (2003) Roles of BRCA1 in DNA damage repair: a link between development and cancer. Hum. Mol. Genet., 12 Spec No. 1, R113-R123.
22. Dohlman, H. G.; Caron, M. G.; Lefkowitz, R. J. (1987) A family of receptors coupled to guanine nucleotide regulatory proteins. Biochemistry, 26, 2657-2664.
23. Draghici, S.; Khatri, P.; Shah, A.; Tainsky, M. A. (2003) Assessing the functional bias of commercial microarrays using the onto-compare database. Biotechniques, Suppl., 55-61.
24. Eisen, M. B.; Spellman, P. T.; Brown, P. O.; Botstein, D. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA, 95, 14863-14868.
25. Ermolaeva, O.; Rastogi, M.; Pruitt, K. D.; Schuler, G. D.; Bittner, M. L.; Chen, Y.; Simon, R.; Meltzer, P.; Trent, J. M.; Boguski, M. S. (1998) Data management and analysis for gene expression arrays. Nat. Genet., 20, 19-23.
26. Evans, R. M. (1988) The steroid and thyroid hormone receptor superfamily. Science, 240, 889-895.
27. Filardo, E. J. (2002) Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer. J. Steroid Biochem. Mol. Biol., 80, 231-238.
28. Frodin, M.; Gammeltoft, S. (1999) Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol. Cell. Endocrinol., 151, 65-77.
29. Fry, M. J. (2001) Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play? Breast Cancer Res., 3, 304-312.
30. Fukuhara, S.; Marinissen, M. J.; Chiariello, M.; Gutkind, J. S. (2000) Signaling from G-Protein-Coupled Receptors to the Nucleus. Signaling Network and Cell Cycle Control, Ed. Gutkind, J. S. Humana Press, New Jersey, pp 83-98.
31. Gagne, D.; Balaguer, P.; Demirpence, E.; Chabret, C.; Trousse, F.; Nicolas, J. C.; Pons, M. (1994) Stable luciferase transfected cells for studying steroid receptor biological activity. J. Biolumin. Chemilumin., 9, 201-209.
32. Gaido, K. W.; Leonard, L. S.; Lovell, S.; Gould, J. C.; Babai, D.; Portier, C. J.; McDonnell, D. P. (1997) Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol. Appl. Pharmacol., 143, 205-212.
33. Giraud, A. S. (2000) Trefoil peptide and EGF receptor/ligand transgenic mice. Am. J. Physiol. Gastrointest. Liver Physiol., 278, G501-G506.
34. Goesmann, A.; Haubrock, M.; Meyer, F.; Kalinowski, J.; Giegerich, R. (2002) PathFinder: reconstruction and dynamic visualization of metabolic pathways. Bioinformatics, 18, 124-129.
35. Gompel, A.; Somai, S.; Chaouat, M.; Kazem, A.; Kloosterboer, H. J.; Beusman, I.; Forgez, P.; Mimoun, M.; Rostene, W. (2000) Hormonal regulation of apoptosis in breast cells and tissues. Steroids, 65, 593-598.
36. Graves, P. R.; Haystead, T. A. J. (2003) Proteomics and the molecular biologist. Handbook of Proteomic Methods, Ed. Conn PM. Humana Press, New Jersey. pp. 3-16.
37. Grese, T. A.; Dodge, J. A. (1998) Selective estrogen receptor modulators (SERMs). Curr. Pharm. Des., 4, 71-92.
38. Grosu, P.; Townsend, J. P.; Hartl, D. L.; Cavalieri, D. (2002) Pathway Processor: a tool for integrating whole-genome expression results into metabolic networks. Genome Res., 12, 1121-1126.
39. Gschwendt, M. (1999) Protein kinase C delta. Eur. J. Biochem., 259, 555-564.
40. Gustafsson, J. A. (1999) Estrogen receptor beta - a new dimension in estrogen mechanism of action. J. Endocrinol. 163, 379-383.
41. Gustafsson, J. A. (2003) What pharmacologists can learn from recent advances in estrogen signalling. Trends Pharmacol. Sci., 24, 479-485.
42. Herrero, J.; Al-Shahrour, F.; Diaz-Uriarte, R.; Mateos, A.; Vaquerizas, J. M.; Santoyo, J.; Dopazo, J. (2003) GEPAS: A web-based resource for microarray gene expression data analysis. Nucleic Acids Res., 31, 3461-3467.
43. Hoogenboom, L. A. P.; de Haan, L.; Hooijerink, D.; Bor, G.; Murk, A. J.; Brouwer, A. (2001) Estrogenic activity of estradiol and its metabolites in the ER-CALUX assay with human T47D breast cells. AP MIS, 109, 101-107.
44. Improta-Brears, T.; Whorton, A. R.; Codazzi, F.; York, J. D.; Meyer, T.; McDonnell, D. P. (1999) Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc. Natl. Acad. Sci. USA, 96, 4686-4691.
45. Ing, N. H.; O'Malley, B. W. (1995) The steroid hormone receptor superfamily: molecular mechanisms of action. Molecular Endocrinology: Basic Concepts and Clinical Correlations, Ed. Weintraub, B. D. Raven Press, New York, pp. 195-215.
46. Inoue, A.; Yoshida, N.; Omoto, Y.; Oguchi, S.; Yamori, T.; Kiyama, R.; Hayashi, S. (2002) Development of cDNA microarray for expression profiling of estrogen-responsive genes. J. Mol. Endocrinol., 29, 175-192.
47. Inoue, A.; Omoto, Y.; Yamaguchi, Y.; Kiyama, R.; Hayashi, S. (2004) Transcription factor EGR3 is involved in the estrogen-signaling pathway in breast cancer cells. J. Mol. Endocrinol., 32, 649-661.
48. Joel, P. B.; Smith, J.; Sturgill, T. W.; Fisher, T. L.; Blenis, J.; Lannigan, D. A. (1998) pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167. Mol. Cell. Biol., 18, 1978-1984.
49. Johnson, G. L.; Lapadat, R. (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science, 298, 1911-1912.
50. Kanehisa, M.; Goto, S.; Kawashima, S.; Nakaya, A. (2002) The KEGG databases at GenomeNet. Nucleic Acids Res., 30, 42-46.
51. Karp, P. D.; Riley, M.; Saier, M.; Paulsen, I. T.; Collado-Vides, J.; Paley, S. M.; Pellegrini-Toole, A.; Bonavides, C.; Gama-Castro, S. (2002) The EcoCyc Database. Nucleic Acids Res., 30, 56-58.
52. Katzenellenbogen, B. S.; Katzenellenbogen, J. A. (2000) Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer. Breast Cancer Res., 2, 335-344.
53. Kim, C. C.; Falkow, S. (2003) Significanqe analysis of lexical bias in microarray data. BMC Bioinformatics, 4, 12.
54. Kim, J. H.; Shim, J. S.; Lee, S. K.; Kim, K. W.; Rha, S. Y.; Chung, H. C.; Kwon, H. J. (2002) Microarray-based analysis of anti-angiogenic activity of demethoxycurcumin on human umbilical vein endothelial cells: crucial involvement of the down-regulation of matrix metalloproteinase. Jpn. J. Cancer Res., 93, 1378-1385.
55. Klipp, E.; Heinrich, R.; Holzhutter, H. G. (2002) Prediction of temporal gene expression. Metabolic opimization by re-distribution of enzyme activities. Eur. J. Biochem., 269, 5406-5413.
56. Knezevic, V.; Emmert-Buck, M. R. (2003) Proteomic Profiling of the Cancer Microenvironment. Handbook of Proteomic Methods, Ed. Conn PM. Humana Press, New Jersey. pp. 309-317.
57. Kohno, H.; Gandini, O.; Curtis, S. W.; Korach, K. S. (1994) Anti-estrogen activity in the yeast transcription system: estrogen receptor mediated agonist response. Steroids, 59, 572-578.
58. Konu, O.; Xu, X.; Ma, J. Z.; Kane, J.; Wang, J.; Shi, S. J.; Li, M. D. (2004) Application of a customized pathway-focused microarray for gene expression profiling of cellular homeostasis upon exposure to nicotine in PC12 cells. Brain Res. Mol. Brain Res., 121, 102-113.
59. Kralli, A.; Bohen, S. P.; Yamamoto, K. R. (1995) LEM1, an ATP-binding-cassette transporter, selectively modulates the biological potency of steroid hormones. Proc. Natl. Acad. Sci. USA, 92, 4701-4705.
60. Lakhani, S. R.; Ashworth, A. (2001) Microarray and histopathological analysis of tumours: the future and the past? Nat. Rev. Cancer. 1, 151-157.
61. Larkin, P.; Folmar, L. C.; Hemmer, M. J.; Poston, A. J.; Denslow, N. D. (2003) Expression profiling of estrogenic compounds using a sheepshead minnow cDNA macroarray. EHP Toxicogenomics, 111, 29-36.
62. Leake, R. E.; Habib, F. K. (1987) Steroid hormone receptors: assay and charact-erization. Steroid Hormones: A Practical Approach, Eds. Green B, Leake RE. IRL Press, Oxford, United Kingdom, pp. 67-92.
63. Lee, Y. T.; Miller, L. D.; Gubin, A. N.; Makhlouf, F.; Wojda, U.; Barrett, A. J.; Liu, E. T.; Miller, J. L. (2001) Transcription patterning of uncoupled proliferation and differentiation in myelodysplastic bone marrow with erythroid-focused arrays. Blood, 98, 1914-1921.
64. Legler, J.; van den Brink, C. E.; Brouwer, A.; Murk, A. J.; van der Saag, P. T.; Vethaak, A. D.; van der Burg, B. (1999) Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicol. Sci., 48, 55-66.
65. Levin, E. R. (2002) Cellular functions of plasma membrane estrogen receptors. Steroids, 67, 471-475.
66. Li, L.; Ljungman, M.; Dixon, J. E. (2000) The human Cdc14 phosphatases interact with and dephosphorylate the tumor suppressor protein p53. J. Biol. Chem., 275, 2410-2414.
67. Liebmann, C. (2001) Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity. Cell. Signal., 13, 777-785.
68. Lohr, K.; Moritz, C.; Contente, A.; Dobbelstein, M. (2003) p21/CDKN1A mediates negative regulation of transcription by p53. J. Biol. Chem., 278, 32507-32516.
69. Lomax, D. P.; Roubal, W. T.; Moore, J. D.; Johnson, L. L. (1998) An enzyme-linked immunosorbent assay (ELISA) for measuring vitellogenin in English sole (Pleuronectes vetulus): development, validation and cross-reactivity with other pleuronectids. Comp. Biochem. Physiol. B. Biochem. Mol. Biol., 121, 425-436.
70. Maggi, A. (2000) Estrogens, apoptosis and cells of neural origin. J. Neural. Transm. Suppl., 59, 115-123.
71. Matthews, J.; Zacharewski, T. (2000) Differential binding affinities of PCBs, HO-PCBs, and aroclors with recombinant human, rainbow trout (Onchorhynkiss mykiss), and green anole (Anolis carolinensis) estrogen receptors, using a semi-high throughput competitive binding assay. Toxicol. Sci., 53, 326-339.
72. McDonnell, D. P. (1999) The Molecular Pharmacology of SERMs. Trends Endocrinol. Metab., 10, 301-311.
73. McDonnell, D. P. (2003) Mining the complexities of the estrogen signaling pathways for novel therapeutics. Endocrinology, 144, 4237-4240.
74. McDonnell, D. P.; Norris, J. D. (2002) Connections and regulation of the human estrogen receptor. Science, 296, 1642-1644.
75. McKenna, N. J.; Lanz, R. B.; O'Malley, B. W. (1999) Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20, 321-344.
76. Muddana, S. S.; Peterson, B. R. (2003) Fluorescent cellular sensors of steroid receptor ligands. Chembiochem., 4, 848-855.
77. Naciff, J. M.; Jump, M. L.; Torontali, S. M.; Carr, G. J.; Tiesman, J. P.; Overmann, G. J.; Daston G. P. (2002) Gene expression profile induced by 17alpha-ethynyl estradiol, bisphenol A, and genistein in the developing female reproductive system of the rat. Toxicol. Sci., 68, 184-199.
78. Newton, S. S.; Collier, E. F.; Hunsberger, J.; Adams, D.; Terwilliger, R.; Selvanayagam, E.; Duman, R. S. (2003) Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J. Neurosci., 23, 10841-10851.
79. Nishikawa, J.; Saito, K.; Goto, J.; Dakeyama, F.; Matsuo, M.; Nishihara, T. (1999) New screening methods for chemicals with hormonal activities using interaction of nuclear hormone receptor with coactivator. Toxicol. Appl. Pharmacol., 154, 76-83.
80. Pandey A, Mann M. (2000) Proteomics to study genes and genomes. Nature, 405, 837-846.
81. Pettersson, K.; Grandien, K.; Kuiper, G. G.; Gustafsson, J. A. (1997) Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol. Endocrinol., 11, 1486-1496.
82. Petersen, D. N.; Tkalcevic, G. T.; Koza-Taylor, P. H.; Turi, T. G.; Brown, T. A. (1998) Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues. Endocrinology, 139, 1082-1092.
83. Polyak, K.; Xia, Y.; Zweier, J. L.; Kinzler, K. W.; Vogelstein, B. (1997) A model for p53-induced apoptosis. Nature, 389, 300-305.
84. Pons, M.; Gagne, D.; Nicolas, J. C.; Mehtali, M. (1990) A new cellular model of response to estrogens: a bioluminescent test to characterize (anti) estrogen molecules. Biotechniques, 9, 450-459.
85. Poola, I.; Koduri, S.; Chatra, S.; Clarke, R. (2000) Identification of twenty alternatively spliced estrogen receptor alpha mRNAs in breast cancer cell lines and tumors using splice targeted primer approach. J. Steroid Biochem. Mol. Biol., 72, 249-258.
86. Purdom, C. E.; Hardiman P. A.; Bye, V. J.; Eno, N. C.; Tyler, C. R.; Sumpter, J. P. (1994) Estrogenic effects of effluents from sewage treatment works. Chem. Ecol., 8, 275-285.
87. Quackenbush, J. (2002) Microarray data normalization and transformation. Nat. Genet., 32 Suppl., 496-501.
88. Rho, J-y.; Wada-Kiyama, Y.; Onishi, Y.; Kiyama, R.; Sakuma, Y. (2004) Expressional regulation of neuronal and cancer-related genes by estrogen in adult female rats. Endocrine Res., (in press.)
89. Rise, M. L.; von Schalburg, K. R.; Brown, G. D.; Mawer, M. A.; Devlin, R. H.; Kuipers, N.; Busby, M.; Beetz-Sargent, M.; Alberto, R.; Gibbs, A. R.; Hunt, P.; Shukin, R.; Zeznik, J. A.; Nelson, C.; Jones, S. R.; Smailus, D. E.; Jones, S. J.; Schein, J. E.; Marra, M. A.; Butterfield, Y. S.; Stott, J. M.; Ng, S. H.; Davidson, W. S.; Koop, B. F. (2004) Development and application of a salmonid EST database and cDNA microarray: data mining and interspecific hybridization characteristics. Genome Res., 14, 478-490.
90. Rich, R. L.; Hoth, L. R.; Geoghegan, K. F.; Brown, T. A.; LeMotte, P. K.; Simons, S. P.; Hensley, P.; Myszka, D.G. (2002) Kinetic analysis of estrogen receptor/ligand interactions. Proc. Natl. Acad. Sci. USA, 99, 8562-8567.
91. Rosner, W.; Hryb, D. J.; Khan, M. S.; Nakhla, A. M.; Romas, N. A. (1999) Androgen and estrogen signaling at the cell membrane via G-proteins and cyclic adenosine monophosphate. Steroids, 64, 100-106.
92. Rotchell, J. M.; Ostrander, G. K. (2003) Molecular markers of endocrine disruption in aquatic organisms. J. Toxicol. Environ. Health. B. Crit. Rev. (Review), 6, 453-496.
93. Routledge, E. J.; Sumpter, J. P. (1996) Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen. Environ. Toxicol. Chem., 15, 241-248.
94. Safe, S. (2001) Molecular biology of the Ah receptor and its role in carcinogenesis. Toxicol. Lett., 120, 1-7.
95. Saito, M.; Tanaka, H.; Takahashi, A.; Yakou, Y. (2002) Comparison of yeast-based estrogen receptor assays. Water Sci. Technol., 46, 349-354.
96. Salman, M.; Reddy, B. R.; Delgado, P.; Stotter, P. L.; Fulcher, L. C.; Chamness, G. C. (1991) 17 alpha-substituted analogs of estradiol for the development of fluorescent estrogen receptor ligands. Steroids, 56, 375-387.
97. Saviozzi, S.; Iazzetti, G.; Caserta, E.; Guffanti, A.; Calogero, R. A. (2004) Microarray data analysis and mining. Methods Mol. Med., 94, 67-90.
98. Schena, M. (2003) Microarray analysis. Wiley-Liss, New Jersey.
99. Seifert, M. (2004) Luminescent enzyme-linked receptor assay for estrogenic compounds. Anal Bioanal Chem., 378, 684-687.
100. Sherry, J.; Gamble, A.; Fielden, M.; Hodson, P.; Burnison, B.; Solomon, K. (1999) An ELISA for brown trout (Salmo trutta) vitellogenin and its use in bioassays for environmental estrogens. Sci. Total Environ., 225, 13-31.
101. Shiau, S. P.; Glasebrook, A.; Hardikar, S. D.; Yang, N. N.; Hershberger, C. L. (1996) Activation of the human estrogen receptor by estrogenic and antiestrogenic compounds in Saccharomyces cerevisiae: a positive selection system. Gene, 179, 205-210.
102. Shupnik, M. A.; Rosenzweig, B. A. (1991) Identification of an estrogen-responsive element in the rat LH beta gene. DNA-estrogen receptor interactions and functional analysis. J. Biol. Chem., 266, 17084-17091.
103. Smeets, J. M.; Rankouhi, T. R.; Nichols, K. M.; Komen, H.; Kaminski, N. E.; Giesy, J. P.; van den Berg, M. (1999) In vitro vitellogenin production by carp (Cyprinus carpio) hepatocytes as a screening method for determining (anti)estrogenic activity of xenobiotics. Toxicol. Appl. Pharmacol., 157, 68-76.
104. Soares, R.; Guo, S.; Russo, J.; Schmitt, F. (2003) Role of the estrogen antagonist ICI 182,780 in vessel assembly and apoptosis of endothelial cells. Ultrastruct. Pathol., 27, 33-39.
105. Soto, A. M.; Lin, T-M.; Justicia, H.; Silvis, R. M.; Sonnenschein, C. (1992) An "in culture" bioassay to assess the estrogenicity of xenobiotics (E-screen). Adv. Modern Environ. Toxicol., 21, 295-309.
106. Soule, H. D.; Vazguez, J.; Long, A.; Albert, S.; Brennan, M. (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst., 51, 1409-1416.
107. Stekel, D. (2003) Microarray Bioinformatics. Cembridge Univ Press, Cambridge, UK.
108. Tanay, A.; Shamir, R. (2001) Computational expansion of genetic networks. Bioinformatics, 17, S270-S278.
109. Tanji, M.; Katz, B. H.; Spink, B. C.; Carpenter, D. O. (2000) Growth inhibition of MCF-7 cells by estrogen is dependent upon a serum factor. Anticancer Res., 20, 2779-2783.
110. Terasaka, T.; Aita, Y.: Inoue, A.; Hayashi, S.; Nishigaki, M.; Aoyagi, K.; Sasaki, H.; Wada-Kiyama, Y.; Sakuma, Y.; Akaba, S.; Tanaka, J.; Sone, H.; Yonemoto, J.; Tanji, M.; Kiyama, R. (2004) Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals. EHP Toxicogenomics, 112, 773-781.
111. Tucker, C. L.; Fields, S. (2001) A yeast sensor of ligand binding. Nat. Biotechnol., 19, 1042-1046.
112. Valafar, F. (2002) Pattern recognition techniques in microarray data analysis: a survey. Ann. NY Acad. Sci., 980, 41-64.
113. Wallqvist, A.; Rabow, A. A.; Shoemaker, R. H.; Sausville, E. A.; Covell, D. G. (2002) Establishing connections between microarray expression data and chemotherapeutic cancer pharmacology. Mol. Cancer Ther., 1, 311-320.
114. White, S. R. (2001) Trefoil peptides in airway epithelium: an important addition to the plethora of peptides. Am. J. Respir. Cell Mol. Biol., 25, 401-404.
115. Wiltshire, C.; Matsushita, M.; Tsukada, S.; Gillespie, D. A.; May, G. H. (2002) A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab (SH3BP5), associates with mitochondria. Biochem. J., 367, 577-585.
116. Wurmbach, E.; Yuen, T.; Sealfon, S. C. (2003) Focused microarray analysis. Methods, 31, 306-316.
117. Zhu, H.; Huang, S.; Dhar, P. (2004) The next step in systems biology: simulating the temporospatial dynamics of molecular network. Bioessays, 26, 68-72.
118. Zysk, J. R.; Johnson, B.; Ozenberger, B. A.; Bingham, B.; Gorski, J. (1995) Selective uptake of estrogenic compounds by Saccharomyces cerevisiae: a mechanism for antiestrogen resistance in yeast expressing the mammalian estrogen receptor. Endocrinology, 136, 1323-1326.